Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients

Early treatment optimization improves clinical outcomes and reduces morbidity and mortality in patients with acute myocardial infarction (AMI). Intravenous beta-adrenoblocker (BAB) therapy, associated with improved survival, is well tolerated by AMI patients. The results of relevant clinical trials...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: S. N. Tereshchenko, I. V. Zhirov
Formato: Artigo
Idioma:Russo
Publicado em: «SILICEA-POLIGRAF» LLC 1970-01-01
Colecção:Кардиоваскулярная терапия и профилактика
Assuntos:
acute myocardial infarction
beta-adrenoblockers
cardiogenic shock
genetic polymorphism
Acesso em linha:https://cardiovascular.elpub.ru/jour/article/view/1497
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados